Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP

[1]  H. Sekihara,et al.  A novel therapy for acute hepatitis utilizing dehydroepiandrosterone in the murine model of hepatitis. , 2004, Biochemical pharmacology.

[2]  K. Ha,et al.  Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation , 2004, Cell Death and Differentiation.

[3]  G. Stassi,et al.  IL-4 Protects Tumor Cells from Anti-CD95 and Chemotherapeutic Agents via Up-Regulation of Antiapoptotic Proteins1 , 2004, The Journal of Immunology.

[4]  R. Schwabe,et al.  Differential requirement for c‐Jun NH2‐terminal kinase in TNF‐α‐and Fas‐mediated apoptosis in hepatocytes , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Christian Trautwein,et al.  Losing balance: cytokine signaling and cell death in the context of hepatocyte injury and hepatic failure. , 2003, European cytokine network.

[6]  C. Falany,et al.  Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[7]  J. Gugenheim,et al.  Spontaneous apoptosis in primary cultures of human and rat hepatocytes: molecular mechanisms and regulation by dexamethasone , 2002, Cell Death and Differentiation.

[8]  Margot Thome,et al.  Regulation of lymphocyte proliferation and death by flip , 2001, Nature Reviews Immunology.

[9]  P. Krammer,et al.  Cellular FLICE-inhibitory Protein Splice Variants Inhibit Different Steps of Caspase-8 Activation at the CD95 Death-inducing Signaling Complex* , 2001, The Journal of Biological Chemistry.

[10]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[11]  J. Gugenheim,et al.  Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction , 2001, Cell Death and Differentiation.

[12]  Yu-Ling Wu,et al.  Upregulation of lipocortin 1 inhibits tumour necrosis factor‐induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immune surveillance , 2000, British journal of haematology.

[13]  Y. M. Kim,et al.  A broad-spectrum caspase inhibitor blocks concanavalin A-induced hepatitis in mice. , 2000, Clinical immunology.

[14]  T. Billiar,et al.  Nitric oxide prevents tumor necrosis factor α–induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S‐nitrosylation of caspase‐8 , 2000, Hepatology.

[15]  T. Billiar,et al.  Cellular Non-heme Iron Content Is a Determinant of Nitric Oxide-mediated Apoptosis, Necrosis, and Caspase Inhibition* , 2000, The Journal of Biological Chemistry.

[16]  E. Bröcker,et al.  Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. , 2000, Cancer research.

[17]  S. Korsmeyer,et al.  Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis , 1999, Nature.

[18]  D. Häussinger,et al.  Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes. , 1999, The Biochemical journal.

[19]  C. Riccardi,et al.  Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. , 1999, Blood.

[20]  Masahiro Yamamoto,et al.  Inhibition by dexamethasone of transforming growth factor β1,–induced apoptosis in rat hepatoma cells: A possible association with Bcl‐xL induction , 1998, Hepatology.

[21]  T. Billiar,et al.  Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms* , 1997, The Journal of Biological Chemistry.

[22]  T. Billiar,et al.  Dexamethasone suppresses iNOS gene expression by upregulating I-κBα and inhibiting NF-κB. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[23]  M. Weiss,et al.  Liver-enriched transcription factors uncoupled from expression of hepatic functions in hepatoma cell lines , 1997, Molecular and Cellular Biology.

[24]  H. Sontheimer,et al.  Cell cycle-dependent expression of a glioma-specific chloride current: proposed link to cytoskeletal changes. , 1997, American journal of physiology. Cell physiology.

[25]  Margot Thome,et al.  Inhibition of death receptor signals by cellular FLIP , 1997, Nature.

[26]  R. Weichselbaum,et al.  Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Simon C Watkins,et al.  Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. , 1997, Journal of medicinal chemistry.

[28]  S. Nagata,et al.  Essential roles of the Fas ligand in the development of hepatitis , 1997, Nature Medicine.

[29]  C. Milliman,et al.  BID: a novel BH3 domain-only death agonist. , 1996, Genes & development.

[30]  E. Reddy,et al.  Transducers of life and death: TNF receptor superfamily and associated proteins. , 1996, Oncogene.

[31]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[32]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[33]  T. Kato,et al.  Inhibition by dexamethasone of human neutrophil apoptosis in vitro. , 1995, Natural immunity.

[34]  D. Paul,et al.  Enhancement of liver cell gap junction protein expression by glucocorticoids. , 1994, Carcinogenesis.

[35]  M. Leist,et al.  Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. , 1994, Journal of immunology.

[36]  C. Marquette,et al.  Tumor necrosis factor-alpha: specific binding sites in rodent brain and pituitary gland. , 1993, European cytokine network.

[37]  C. Lowenstein,et al.  Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Nussler,et al.  Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin , 1992, The Journal of experimental medicine.

[39]  E. Schuetz,et al.  Paradoxical transcriptional activation of rat liver cytochrome P-450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16 alpha-carbonitrile: analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Merćep,et al.  Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. , 1990, Journal of immunology.

[41]  K. Nouri-Aria,et al.  ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILURE , 1988, The Lancet.

[42]  J. Harmon,et al.  Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line , 1979, Journal of cellular physiology.

[43]  McFARLAN Am,et al.  Poliomyelitis and tonsillectomy. , 1948 .

[44]  P. Scheurich,et al.  Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.

[45]  岡野 宏.  Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma , 2003 .

[46]  坂平 英樹.  Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis , 2000 .

[47]  M. Lutter,et al.  Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.

[48]  P. Baeuerle,et al.  NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. , 1997, Advances in immunology.

[49]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.

[50]  W. Fiers,et al.  Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. , 1991, European journal of biochemistry.